The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
α-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 1
Open accessAbstract
With a short particle range and high linear energy transfer, α-emitting radionuclides demonstrate high cell-killing efficiencies. Even with the existence of numerous radionuclides that decay by α-particle emission, only a few of these can reasonably be exploited for therapeutic purposes. Factors including radioisotope availability and physical characteristics (e.g., half-life) can limit their widespread dissemination. The first part of this review will explore the diversity, basic radiochemistry, restrictions, and hurdles of α-emitters.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kratochwil, C., Bruchertseifer, F., Giesel, F. L., Weis, M., Verburg, F. A., Mottaghy, F., Kopka, K., Apostolidis, C., Haberkorn, U., & Morgenstern, A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178673 · Cited by 1,100
Matching chelators to radiometals for radiopharmaceuticals
Price, E. W., & Orvig, C. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60304k · Cited by 1,018
Sgouros, G., Roeske, J. C., McDevitt, M. R., Palm, S., Allen, B. J., Fisher, D. R., Brill, A. B., Song, H., Howell, R. W., & Akabani, G. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058651 · Cited by 552
Self-citationTumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
Self-citationZalutsky, M. R., Reardon, D. A., Akabani, G., Coleman, R. E., Friedman, A. H., Friedman, H. S., McLendon, R. E., Wong, T. Z., & Bigner, D. D. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.046938 · Cited by 410
A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
De Kruijff, R., Wolterbeek, H., & Denkova, A. (2015) · Pharmaceuticals · doi:10.3390/ph8020321 · Cited by 249
Pretargeted Imaging and Therapy
Altai, M., Membreno, R., Cook, B. E., Максимилианович, Т. В., & Zeglis, B. M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.189944 · Cited by 231
Design and synthesis of 225Ac radioimmunopharmaceuticals.
McDevitt, M. R., Ma, D., Simon, J., Frank, R. K., & Scheinberg, D. A. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00167-7 · Cited by 225
Self-citationRadiation risk to low fluences of α particles may be greater than we thought
Zhou, H., Suzuki, M., Randers-Pehrson, G., Vannais, D., Chen, G., Trosko, J. E., Waldren, C. A., & Hei, T. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251524798 · Cited by 217
Molecular Pathways: Targeted α-Particle Radiation Therapy
Baidoo, K. E., Yong, K., & Brechbiel, M. W. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0298 · Cited by 217
Miederer, M., Scheinberg, D. A., & McDevitt, M. R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.009 · Cited by 210
Self-citationAstatine-211-Labeled Radiotherapeutics An Emerging Approach to Targeted Alpha-Particle Radiotherapy
Zalutsky, M., & Vaidyanathan, G. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003399275 · Cited by 202
Astatine-211: Production and Availability
R. Zalutsky, M., & Pruszynski, M. (2011) · Current Radiopharmaceuticalse · doi:10.2174/1874471011104030177 · Cited by 200
Avidin-biotin technology in targeted therapy
Lesch, H. P., Kaikkonen, M. U., Pikkarainen, J. T., & Ylä-Herttuala, S. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003677749 · Cited by 200
Health Risks of Radon and Other Internally Deposited Alpha-Emitters (Beir IV)
(1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.6.1531a · Cited by 188
Carrasquillo, J. A., O’Donoghue, J. A., Pandit-Taskar, N., Humm, J. L., Rathkopf, D. E., Slovin, S. F., Williamson, M. J., Lacuna, K., Aksnes, A.-K., Larson, S. M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2427-6 · Cited by 185
Self-citationProduction of actinium-225 for alpha particle mediated radioimmunotherapy.
Boll, R. A., Malkemus, D., & Mirzadeh, S. (2005) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2004.12.003 · Cited by 171
Chappell, L. L., Dadachova, E., Milenic, D. E., Garmestani, K., Wu, C., & Brechbiel, M. W. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00086-4 · Cited by 159
A nuclear chocolate box: the periodic table of nuclear medicine
Blower, P. J. (2014) · Dalton Transactions · doi:10.1039/c4dt02846e · Cited by 155
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.
McDevitt, M. R., Finn, R. D., Sgouros, G., Ma, D., & Scheinberg, D. A. (1999) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(98)00151-1 · Cited by 138
Self-citationGuérard, F., Gestin, J., & Brechbiel, M. W. (2012) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1292 · Cited by 131
Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes
Deal, K. A., Davis, I. A., Mirzadeh, S., Kennel, S. J., & Brechbiel, M. W. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990141f · Cited by 130
Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy
McLaughlin, M. F., Woodward, J. D., Boll, R. A., Wall, J. S., Rondinone, A. J., Kennel, S. J., Mirzadeh, S., & Robertson, J. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054531 · Cited by 130
Schwartz, J., Jaggi, J. S., O’Donoghue, J. A., Ruan, S., McDevitt, M. R., Larson, S. M., Scheinberg, D. A., & Humm, J. L. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/56/3/012 · Cited by 128
Self-citationGriswold, J. R., Medvedev, D., Engle, J. W., Copping, R., Fitzsimmons, J., Radchenko, V., Cooley, J. C., Fassbender, M. E., Denton, D. L., Murphy, K. E., et al. (2016) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2016.09.026 · Cited by 119
Antitumor Immunity Induced after α Irradiation
Gorin, J., Ménager, J., Gouard, S., Maurel, C., Guilloux, Y., Faivre-Chauvet, A., Morgenstern, A., Bruchertseifer, F., Chérel, M., Davodeau, F., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.04.002 · Cited by 118
Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
Yong, K. J., & Brechbiel, M. W. (2011) · Dalton Transactions · doi:10.1039/c0dt01387k · Cited by 111
Cancer imaging and therapy with bispecific antibody pretargeting
Goldenberg, D. M., Chatal, J., Barbet, J., Boerman, O. C., & Sharkey, R. M. (2007) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2007.04.003 · Cited by 111
Wulbrand, C., Seidl, C., Gaertner, F. C., Bruchertseifer, F., Morgenstern, A., Essler, M., & Senekowitsch–Schmidtke, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064730 · Cited by 100
Efforts to Control the Errant Products of a Targeted In vivo Generator
Singh Jaggi, J., Kappel, B. J., McDevitt, M. R., Sgouros, G., Flombaum, C. D., Cabassa, C., & Scheinberg, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3096 · Cited by 98
Self-citationTreatment of solid tumors by interstitial release of recoiling short-lived alpha emitters
Arazi, L., Cooks, T., Schmidt, M. T., Keisari, Y., & Kelson, I. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/16/021 · Cited by 93
Maguire, W. F., McDevitt, M. R., Smith-Jones, P. M., & Scheinberg, D. A. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.138347 · Cited by 93
Self-citationThe Future of Radioligand Therapy: α, β, or Both?
Haberkorn, U., Giesel, F., Morgenstern, A., & Kratochwil, C. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.190124 · Cited by 88
Bioorthogonal chemistry: implications for pretargeted nuclear (PET/SPECT) imaging and therapy.
Knight, J. C., & Cornelissen, B. T. (2014) · Oxford University Research Archive (ORA) (University of Oxford) · Cited by 86
Astatine Radiopharmaceuticals: Prospects and Problems
Vaidyanathan, G., & Zalutsky, M. R. (2008) · Current Radiopharmaceuticals · doi:10.2174/1874471010801030177 · Cited by 81
Methodology for labeling proteins and peptides with lead-212 (212Pb)
Baidoo, K. E., Milenic, D. E., & Brechbiel, M. W. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.01.010 · Cited by 73
Dauer, L. T., Williamson, M. J., Humm, J. L., O’Donoghue, J. A., Ghani, R., Awadallah, R., Carrasquillo, J. A., Pandit-Taskar, N. D., Aksnes, A.-K., Biggin, C., et al. (2014) · Health Physics · doi:10.1097/hp.0b013e3182a82b37 · Cited by 71
Self-citationAn efficient chelator for complexation of thorium-227
Ramdahl, T., Bonge‐Hansen, H. T., Ryan, O. B., Larsen, Å., Herstad, G., Sandberg, M., Bjerke, R. M., Grant, D., Brevik, E. M., & Cuthbertson, A. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.07.034 · Cited by 71
Larsen, R. H., Saxtorph, H., Skydsgaard, M., Borrebæk, J., Jónasdóttir, T. J., Bruland, Ø. S., Klastrup, S., Harling, R., & Ramdahl, T. (2006) · PubMed · Cited by 66
Søyland, C. (2000) · International Journal of Radiation Biology · doi:10.1080/09553000050151583 · Cited by 57
Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy
Dahle, J., Borrebæk, J., Melhus, K. B., Bruland, Ø. S., Salberg, G., Olsen, D. R., & Larsen, R. H. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.12.004 · Cited by 57
Jónasdóttir, T. J., Fisher, D. R., Borrebæk, J., Bruland, Ø. S., & Larsen, R. H. (2006) · PubMed · Cited by 53
Vascular Targeted Radioimmunotherapy for the Treatment of Glioblastoma
Behling, K., Maguire, W. F., Puebla, J. C. L., Sprinkle, S. R., Ruggiero, A., O’Donoghue, J. A., Gutin, P. H., Scheinberg, D. A., & McDevitt, M. R. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.171371 · Cited by 49
Self-citationConsequences of Cytoplasmic Irradiation: Studies from Microbeam
Zhou, H., Hong, M., Chai, Y., & Hei, T. K. (2009) · Journal of Radiation Research · doi:10.1269/jrr.08120s · Cited by 44
Cooks, T., Tal, M., Raab, S., Efrati, M., Reitkopf, S., Lazarov, E., Etzyoni, R., Schmidt, M. T., Arazi, L., Kelson, I., et al. (2012) · PubMed · Cited by 44
Yao, Z., Zhang, M., Garmestani, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0171 · Cited by 41
Remodeling the Vascular Microenvironment of Glioblastoma with α-Particles
Behling, K., Maguire, W. F., Gialleonardo, V. D., Heeb, L. E. M., Hassan, I. F., Veach, D. R., Keshari, K. R., Gutin, P. H., Scheinberg, D. A., & McDevitt, M. R. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.173559 · Cited by 39
Self-citation227Th-EDTMP: A potential therapeutic agent for bone metastasis
Washiyama, K., Amano, R., Sasaki, J., Kinuya, S., Tonami, N., Shiokawa, Y., & Mitsugashira, T. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.05.001 · Cited by 35
Radium-224 Retention, Distribution, and Dosimetry in Beagles
Lloyd, R. D., Mays, C. W., Taylor, G. N., Atherton, D. R., Bruenger, F. W., & Jones, C. W. (1982) · Radiation Research · doi:10.2307/3576005 · Cited by 24
Choice of alpha-probe operating voltage to suit a wide range of conditions
Bosley, R. B., & Simpson, J. A. (2002) · Journal of Radiological Protection · doi:10.1088/0952-4746/22/3/304 · Cited by 4
Cited by
Radiotheranostics in oncology: current challenges and emerging opportunities
Bodei, L., Herrmann, K., Schöder, H., Scott, A. M., & Lewis, J. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00652-y · Cited by 414
Self-citationRadiolabelling of nanomaterials for medical imaging and therapy
Pellico, J., Gawne, P. J., & T. M. de Rosales, R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00384k · Cited by 304
Targeted alpha therapy: progress in radionuclide production, radiochemistry, and applications.
Nelson, B. J. B., Andersson, J. D., & Wuest, F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010049 · Cited by 194
“227Th and 223Ra are both nanogenerators, releasing up to four α particles during the decay chain, and their γ emissions allow for imaging [1].”
BackgroundInfluentialShi, M., Jakobsson, V., Greifenstein, L., Khong, P.-L., Chen, X., Baum, R. P., & Zhang, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1034315 · Cited by 68
Metadata
- Authors
- Poty, S., Francesconi, L. C., McDevitt, M. R., Morris, M. J., & Lewis, J. S.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2018-03-15
- Volume
- 59
- Issue
- 6
- Pages
- 878-884
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2790547014
- Cited by
- 256
- References
- 50
- FWCI
- 11.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.